BioCryst Pharma (BCRX) Reports Q4 Loss Per Share of 6c

Go back to BioCryst Pharma (BCRX) Reports Q4 Loss Per Share of 6c
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.70 +0.27 (3.20%)
Previous Close $8.43    52 Week High $10.98 
Open $8.54    52 Week Low $1.63 
Day High $8.73    P/E N/A 
Day Low $8.43    EPS $-0.68 
Volume 5,219,505